Overcoming drug resistance microspheres combined with photothermal ablation reinforce transcatheter arterial chemoembolization of hepatocellular carcinoma
Year: 2025
Type: article
Abstract: Drug-eluting microspheres (DEMs) are key for transcatheter arterial chemoembolization (TACE) in advanced hepatocellular carcinoma (HCC), but face challenges like tumor multidrug resistance (MDR) and poor post-TACE outcomes. Here we show a dual-effect microsphere (PTIMS) co-encapsulating idarubicin (IDA) and tariquidar (TQR) for simultaneous chemotherapy and MDR reversal, plus minimally invasive photothermal therapy (PTT) to boost antitumor efficacy. Physicochemical tests confirm IDA/TQR loading in PTIMS, with PTT accelerating drug release. In vitro, PTIMS-PTT strongly inhibits H22 cell proliferation, migration and invasion by downregulating membrane P-glycoprotein (P-gp), promoting apoptosis and reducing IDA efflux. In vivo, it suppresses tumor growth in murine H22 models (upregulating TNF-α, downregulating Ki67/P-gp) and inhibits progression in rabbit VX2 liver tumors via robust embolization. PTIMS offers a promising strategy to enhance TACE efficacy, with high clinical translation potential. This study reports dual-effect embolized microspheres integrated with photothermal ablation for the treatment of hepatocellular carcinoma via transcatheter arterial chemoembolization.
Source: Communications Materials
Authors: Jiheng Shan, Chengzhi Zhang, Yiming Liu, Bingtong Yue, Bin Han, Jing Li, Guodun Zheng, Kunpeng Wu, Huijuan Wu, Yiran Wang, Qingqing He, Xiaonan Shan, Zongming Li, Ping Wu, Kewei Ren, Zhen Li, Jianzhuang Ren, Linyong Du, Yanan Zhao, Xinwei Han
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,690
Award: G7562755568
OpenAlex ID: W4416631707
